You are currently viewing a new version of our website. To view the old version click .

Cytotoxicity on Pharmaceutical Interactions in Chemotherapy

This special issue belongs to the section “Molecular Toxicology“.

Special Issue Information

Dear Colleagues,

A wide variety of anticancer drugs are used for chemotherapy depending on the type of cancer. Many of these anticancer agents have cytotoxic effects on tumor cells as a major mechanism for their anticancer effects. However, insufficient tumor cell selectivity may result in a risk of comorbid side effects, including hematotoxicity due to myelosuppression. Because chemotherapy is often achieved using a combination of drugs, the relationship between these antitumor effects and side effects and anticancer drugs is complex.

The purpose of this Special Issue is to integrate knowledge, including mechanisms of clinically and biochemically useful expression of pharmacological interactions. In other words, it is expected that findings relevant to this topic will be based on the results of biochemical studies through in vivo and in vitro experiments and data accumulated in a variety of clinical studies, including database studies. This combined knowledge allows molecular interpretations of chemotherapy and may contribute to improved clinical outcomes of anticancer therapy.

Prof. Dr. Yoshihiro Uesawa
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • tumor specificity
  • PK/PD interaction
  • adverse effect
  • anticancer drug
  • cytotoxicity
  • chemotherapy
  • cell signaling
  • molecular mechanisms
  • translational research

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Int. J. Mol. Sci. - ISSN 1422-0067